{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:13:41Z","timestamp":1790662421788,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T00:00:00Z","timestamp":1661904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T00:00:00Z","timestamp":1661904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Hepatic progenitor cells (HPCs) hold tremendous potential for liver regeneration, but their well-known limitation of proliferation hampers their broader use. There is evidence that laminin is required for the proliferation of HPCs, but the laminin isoform that plays the dominant role and the key intracellular downstream targets that mediate the regulation of HPC proliferation have yet to be determined. Here we showed that p53 expression increased gradually and reached maximal levels around 8 days when laminin \u03b14, \u03b15, \u03b22, \u03b21, and \u03b31 subunit levels also reached a maximum during HPC activation and expansion. Laminin-521 (LN-521) promoted greater proliferation of HPCs than do laminin, matrigel or other laminin isoforms. Inactivation of p53 by PFT-\u03b1 or Ad-p53\n                    <jats:sup>V143A<\/jats:sup>\n                    inhibited the promotion of proliferation by LN-521. Further complementary MRI and bioluminescence imaging analysis showed that p53 inactivation decreased the proliferation of transplanted HPCs in vivo. p53 was activated by LN-521 through the Integrin \u03b16\u03b21\/FAK-Src-Paxillin\/Akt axis. Activated p53 was involved in the nuclear translocation of CDK4 and inactivation of Rb by inducing p27\n                    <jats:sup>Kip1<\/jats:sup>\n                    . Taken together, this study identifies LN-521 as an ideal candidate substrate for HPC culture and uncovers an unexpected positive role for p53 in regulating proliferation of HPCs, which makes it a potential target for HPC-based regenerative medicine.\n                  <\/jats:p>","DOI":"10.1038\/s41392-022-01107-7","type":"journal-article","created":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T20:04:43Z","timestamp":1661889883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["p53 positively regulates the proliferation of hepatic progenitor cells promoted by laminin-521"],"prefix":"10.1038","volume":"7","author":[{"given":"Mingyang","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyao","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangde","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bixiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8636-0493","authenticated-orcid":false,"given":"Xiaoping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,31]]},"reference":[{"key":"1107_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12929-018-0441-5","volume":"25","author":"CS Chien","year":"2018","unstructured":"Chien, C. S. et al. Cells responsible for liver mass regeneration in rats with 2-acetylaminofluorene\/partial hepatectomy injury. J. Biomed. Sci. 25, 39 (2018).","journal-title":"J. Biomed. Sci."},{"key":"1107_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1053\/j.gastro.2013.11.034","volume":"146","author":"MJ Williams","year":"2014","unstructured":"Williams, M. J., Clouston, A. D. & Forbes, S. J. Links between hepatic fibrosis, ductular reaction, and progenitor cell expansion. Gastroenterology 146, 349\u2013356 (2014).","journal-title":"Gastroenterology"},{"key":"1107_CR3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1136\/gut.2010.224436","volume":"60","author":"YN Kallis","year":"2011","unstructured":"Kallis, Y. N. et al. Remodelling of extracellular matrix is a requirement for the hepatic progenitor cell response. Gut 60, 525\u2013533 (2011).","journal-title":"Gut"},{"key":"1107_CR4","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1136\/gut.2009.182345","volume":"59","author":"S Lorenzini","year":"2010","unstructured":"Lorenzini, S. et al. Characterisation of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver. Gut 59, 645\u2013654 (2010).","journal-title":"Gut"},{"key":"1107_CR5","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1136\/gutjnl-2013-306290","volume":"64","author":"W-C Hsieh","year":"2015","unstructured":"Hsieh, W.-C. et al. Galectin-3 regulates hepatic progenitor cell expansion during liver injury. Gut 64, 312\u2013321 (2015).","journal-title":"Gut"},{"key":"1107_CR6","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1091\/mbc.e06-09-0848","volume":"18","author":"N Tanimizu","year":"2007","unstructured":"Tanimizu, N., Miyajima, A. & Mostov, K. E. Liver progenitor cells develop cholangiocyte-type epithelial polarity in three-dimensional culture. Mol. Biol. Cell 18, 1472\u20131479 (2007).","journal-title":"Mol. Biol. Cell"},{"key":"1107_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4161\/cam.22826","volume":"7","author":"M Aumailley","year":"2013","unstructured":"Aumailley, M. The laminin family. Cell Adh. Migr. 7, 48\u201355 (2013).","journal-title":"Cell Adh. Migr."},{"key":"1107_CR8","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/0092-8674(94)90379-4","volume":"76","author":"V Duli\u0107","year":"1994","unstructured":"Duli\u0107, V. et al. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76, 1013\u20131023 (1994).","journal-title":"Cell"},{"key":"1107_CR9","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/hep.26233","volume":"57","author":"S Kurinna","year":"2013","unstructured":"Kurinna, S. et al. p53 regulates a mitotic transcription program and determines ploidy in normal mouse liver. Hepatology 57, 2004\u20132013 (2013).","journal-title":"Hepatology"},{"key":"1107_CR10","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.bbrc.2013.12.030","volume":"443","author":"EM Abdelalim","year":"2014","unstructured":"Abdelalim, E. M. & Tooyama, I. Knockdown of p53 suppresses Nanog expression in embryonic stem cells. Biochem. Biophys. Res. Commun. 443, 652\u2013657 (2014).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1107_CR11","first-page":"1001","volume":"1","author":"UM Moll","year":"2003","unstructured":"Moll, U. M. & Petrenko, O. The MDM2-p53 Interaction. Mol. Cancer Res. 1, 1001\u20131008 (2003).","journal-title":"Mol. Cancer Res."},{"key":"1107_CR12","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1038\/sj.cdd.4401677","volume":"12","author":"J Bar","year":"2005","unstructured":"Bar, J. et al. The PI3K inhibitor LY294002 prevents p53 induction by DNA damage and attenuates chemotherapy-induced apoptosis. Cell Death Differ. 12, 1578\u20131587 (2005).","journal-title":"Cell Death Differ."},{"key":"1107_CR13","doi-asserted-by":"publisher","first-page":"11598","DOI":"10.1073\/pnas.181181198","volume":"98","author":"LD Mayo","year":"2001","unstructured":"Mayo, L. D. & Donner, D. B. A phosphatidylinositol 3-kinase\/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc. Natl Acad. Sci. USA 98, 11598\u201311603 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1107_CR14","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","volume":"1773","author":"JA McCubrey","year":"2007","unstructured":"McCubrey, J. A. et al. Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim. Biophys. Acta Mol. Cell Res. 1773, 1263\u20131284 (2007).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"1107_CR15","doi-asserted-by":"publisher","first-page":"5913","DOI":"10.1007\/s12035-017-0814-x","volume":"55","author":"M Gao","year":"2018","unstructured":"Gao, M. & Zhao, L.-R. Turning death to growth: hematopoietic growth factors promote neurite outgrowth through MEK\/ERK\/p53 pathway. Mol. Neurobiol. 55, 5913\u20135925 (2018).","journal-title":"Mol. Neurobiol."},{"key":"1107_CR16","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1074\/jbc.M604953200","volume":"282","author":"M Malml\u00f6f","year":"2007","unstructured":"Malml\u00f6f, M., Roudier, E., H\u00f6gberg, J. & Stenius, U. MEK-ERK-mediated phosphorylation of Mdm2 at Ser-166 in hepatocytes. J. Biol. Chem. 282, 2288\u20132296 (2007).","journal-title":"J. Biol. Chem."},{"key":"1107_CR17","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/0092-8674(93)90499-G","volume":"75","author":"J Wade Harper","year":"1993","unstructured":"Wade Harper, J., Adami, G. R., Wei, N., Keyomarsi, K. & Elledge, S. J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805\u2013816 (1993).","journal-title":"Cell"},{"key":"1107_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0092-8674(94)90573-8","volume":"78","author":"H Toyoshima","year":"1994","unstructured":"Toyoshima, H. & Hunter, T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78, 67\u201374 (1994).","journal-title":"Cell"},{"key":"1107_CR19","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","volume":"13","author":"CJ Sherr","year":"1999","unstructured":"Sherr, C. J. & Roberts, J. M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501\u20131512 (1999).","journal-title":"Genes Dev."},{"key":"1107_CR20","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1101\/gad.11.7.847","volume":"11","author":"J LaBaer","year":"1997","unstructured":"LaBaer, J. et al. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11, 847\u2013862 (1997).","journal-title":"Genes Dev."},{"key":"1107_CR21","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/emboj\/18.6.1571","volume":"18","author":"M Cheng","year":"1999","unstructured":"Cheng, M. et al. The p21(Cip1) and p27(Kip1) CDK \u2018inhibitors\u2019 are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18, 1571\u20131583 (1999).","journal-title":"EMBO J."},{"key":"1107_CR22","first-page":"G115","volume":"285","author":"GP Ilyin","year":"2003","unstructured":"Ilyin, G. P., Glaise, D., Gilot, D., Baffet, G. & Guguen-Guillouzo, C. Regulation and role of p21 and p27 cyclin-dependent kinase inhibitors during hepatocyte differentiation and growth. Am. J. Physiol. Liver Physiol. 285, G115\u2013G127 (2003).","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"1107_CR23","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1038\/sj.onc.1210937","volume":"27","author":"L Wier\u00f8d","year":"2008","unstructured":"Wier\u00f8d, L. et al. Activation of the p53\u2013p21Cip1 pathway is required for CDK2 activation and S-phase entry in primary rat hepatocytes. Oncogene 27, 2763\u20132771 (2008).","journal-title":"Oncogene"},{"key":"1107_CR24","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.molcel.2019.03.020","volume":"74","author":"BR Topacio","year":"2019","unstructured":"Topacio, B. R. et al. Cyclin D-Cdk4,6 drives cell-cycle progression via the retinoblastoma protein\u2019s C-terminal helix. Mol. Cell 74, 758\u2013770.e4 (2019).","journal-title":"Mol. Cell"},{"key":"1107_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.matbio.2005.12.001","volume":"25","author":"R Nishiuchi","year":"2006","unstructured":"Nishiuchi, R. et al. Ligand-binding specificities of laminin-binding integrins: a comprehensive survey of laminin\u2013integrin interactions using recombinant \u03b13\u03b21, \u03b16\u03b21, \u03b17\u03b21 and \u03b16\u03b24 integrins. Matrix Biol. 25, 189\u2013197 (2006).","journal-title":"Matrix Biol."},{"key":"1107_CR26","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/jcb.21019","volume":"99","author":"Z F\u00e1bi\u00e1n","year":"2006","unstructured":"F\u00e1bi\u00e1n, Z., Vecserny\u00e9s, M., Pap, M. & Szeber\u00e9nyi, J. The effects of a mutant p53 protein on the proliferation and differentiation of PC12 rat phaeochromocytoma cells. J. Cell. Biochem. 99, 1431\u20131441 (2006).","journal-title":"J. Cell. Biochem."},{"key":"1107_CR27","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S0092-8674(00)81519-6","volume":"98","author":"JW Harbour","year":"1999","unstructured":"Harbour, J. W., Luo, R. X., Dei Santi, A., Postigo, A. A. & Dean, D. C. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98, 859\u2013869 (1999).","journal-title":"Cell"},{"key":"1107_CR28","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ceb.2006.08.011","volume":"18","author":"SK Mitra","year":"2006","unstructured":"Mitra, S. K. & Schlaepfer, D. D. Integrin-regulated FAK\u2013Src signaling in normal and cancer cells. Curr. Opin. Cell Biol. 18, 516\u2013523 (2006).","journal-title":"Curr. Opin. Cell Biol."},{"key":"1107_CR29","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1111\/jcmm.14263","volume":"23","author":"X Jin","year":"2019","unstructured":"Jin, X. et al. RBM10 inhibits cell proliferation of lung adenocarcinoma via RAP1\/AKT\/CREB signalling pathway. J. Cell. Mol. Med. 23, 3897\u20133904 (2019).","journal-title":"J. Cell. Mol. Med."},{"key":"1107_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3976","volume":"4","author":"I Serrano","year":"2013","unstructured":"Serrano, I., McDonald, P. C., Lock, F., Muller, W. J. & Dedhar, S. Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase. Nat. Commun. 4, 2976 (2013).","journal-title":"Nat. Commun."},{"key":"1107_CR31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.stemcr.2016.07.006","volume":"7","author":"L Vitillo","year":"2016","unstructured":"Vitillo, L., Baxter, M., Iskender, B., Whiting, P. & Kimber, S. J. Integrin-associated focal adhesion kinase protects human embryonic stem cells from apoptosis, detachment, and differentiation. Stem Cell Rep. 7, 167\u2013176 (2016).","journal-title":"Stem Cell Rep."},{"key":"1107_CR32","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/hep.510270309","volume":"27","author":"LCE Ohlson","year":"1998","unstructured":"Ohlson, L. C. E., Koroxenidou, L. & H\u00e4llstr\u00f6m, I. P. Inhibition of in vivo rat liver regeneration by 2-acetylaminofluorene affects the regulation of cell cycle-related proteins. Hepatology 27, 691\u2013696 (1998).","journal-title":"Hepatology"},{"key":"1107_CR33","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1038\/onc.2011.394","volume":"31","author":"MV Astle","year":"2012","unstructured":"Astle, M. V. et al. AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy. Oncogene 31, 1949\u20131962 (2012).","journal-title":"Oncogene"},{"key":"1107_CR34","doi-asserted-by":"publisher","first-page":"9084","DOI":"10.1158\/0008-5472.CAN-10-0159","volume":"70","author":"P Taneja","year":"2010","unstructured":"Taneja, P. et al. Critical roles of DMP1 in human epidermal growth factor receptor 2\/neu-Arf-p53 signaling and breast cancer development. Cancer Res. 70, 9084\u20139094 (2010).","journal-title":"Cancer Res."},{"key":"1107_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2208-7","volume":"11","author":"A Marin Navarro","year":"2020","unstructured":"Marin Navarro, A. et al. p53 controls genomic stability and temporal differentiation of human neural stem cells and affects neural organization in human brain organoids. Cell Death Dis. 11, 52 (2020).","journal-title":"Cell Death Dis."},{"key":"1107_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/cmmi.1553","volume":"9","author":"P Danhier","year":"2014","unstructured":"Danhier, P. et al. Multimodal cell tracking of a spontaneous metastasis model: comparison between MRI, electron paramagnetic resonance and bioluminescence. Contrast Media Mol. Imaging 9, 143\u2013153 (2014).","journal-title":"Contrast Media Mol. Imaging"},{"key":"1107_CR37","first-page":"757","volume":"7","author":"C Zhu","year":"2013","unstructured":"Zhu, C., Coombe, D. R., Zheng, M. H., Yeoh, G. C. T. & Li, L. Liver progenitor cell interactions with the extracellular matrix. J. Tissue Eng. Regen. Med. 7, 757\u2013766 (2013).","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"1107_CR38","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/carcin\/23.3.435","volume":"23","author":"ML Dumble","year":"2002","unstructured":"Dumble, M. L., Croager, E. J., Yeoh, G. C. T. & Quail, E. A. Generation and characterization of p53 null transformed hepatic progenitor cells: oval cells give rise to hepatocellular carcinoma. Carcinogenesis 23, 435\u2013445 (2002).","journal-title":"Carcinogenesis"},{"key":"1107_CR39","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1101\/gad.11.11.1479","volume":"11","author":"J Lukas","year":"1997","unstructured":"Lukas, J. et al. Cyclin E-induced S phase without activation of the pRb\/E2F pathway. Genes Dev. 11, 1479\u20131492 (1997).","journal-title":"Genes Dev."},{"key":"1107_CR40","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0960-9822(06)00301-0","volume":"7","author":"X Leng","year":"1997","unstructured":"Leng, X., Connell-Crowley, L., Goodrich, D. & Harper, J. W. S-phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation. Curr. Biol. 7, 709\u2013712 (1997).","journal-title":"Curr. Biol."},{"key":"1107_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0960-9822(98)70021-1","volume":"8","author":"L Connell-Crowley","year":"1998","unstructured":"Connell-Crowley, L., Elledge, S. J. & Harper, J. W. G1 cyclin-dependent kinases are sufficient to initiate DNA synthesis in quiescent human fibroblasts. Curr. Biol. 8, 65\u201368 (1998).","journal-title":"Curr. Biol."},{"key":"1107_CR42","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nrm3567","volume":"14","author":"FA Dick","year":"2013","unstructured":"Dick, F. A. & Rubin, S. M. Molecular mechanisms underlying RB protein function. Nat. Rev. Mol. Cell Biol. 14, 297\u2013306 (2013).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1107_CR43","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","volume":"75","author":"WS el-Deiry","year":"1993","unstructured":"el-Deiry, W. S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817\u2013825 (1993).","journal-title":"Cell"},{"key":"1107_CR44","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jsbmb.2018.08.011","volume":"185","author":"S-P Hsu","year":"2019","unstructured":"Hsu, S.-P., Lin, P.-H., Chou, C.-M. & Lee, W.-S. Progesterone up-regulates p27 through an increased binding of the progesterone receptor-A-p53 protein complex onto the non-canonical p53 binding motif in HUVEC. J. Steroid Biochem. Mol. Biol. 185, 163\u2013171 (2019).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"1107_CR45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/ng0492-45","volume":"1","author":"WS el-Deiry","year":"1992","unstructured":"el-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W. & Vogelstein, B. Definition of a consensus binding site for p53. Nat. Genet. 1, 45\u20139 (1992).","journal-title":"Nat. Genet."},{"key":"1107_CR46","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1007\/s00018-008-8441-3","volume":"65","author":"S-P Hsu","year":"2008","unstructured":"Hsu, S.-P., Ho, P.-Y., Juan, S.-H., Liang, Y.-C. & Lee, W.-S. Progesterone inhibits human endothelial cell proliferation through a p53-dependent pathway. Cell. Mol. Life Sci. 65, 3839\u20133850 (2008).","journal-title":"Cell. Mol. Life Sci."},{"key":"1107_CR47","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1083\/jcb.127.2.467","volume":"127","author":"JP Tassan","year":"1994","unstructured":"Tassan, J. P., Schultz, S. J., Bartek, J. & Nigg, E. A. Cell cycle analysis of the activity, subcellular localization, and subunit composition of human CAK (CDK-activating kinase). J. Cell Biol. 127, 467\u2013478 (1994).","journal-title":"J. Cell Biol."},{"key":"1107_CR48","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1021\/bi015763t","volume":"41","author":"EA Bienkiewicz","year":"2002","unstructured":"Bienkiewicz, E. A., Adkins, J. N. & Lumb, K. J. Functional consequences of preorganized helical structure in the intrinsically disordered cell-cycle inhibitor p27Kip1. Biochemistry 41, 752\u2013759 (2002).","journal-title":"Biochemistry"},{"key":"1107_CR49","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/cercor\/bhl091","volume":"17","author":"S Schmetsdorf","year":"2007","unstructured":"Schmetsdorf, S., G\u00e4rtner, U. & Arendt, T. Constitutive expression of functionally active cyclin-dependent kinases and their binding partners suggests noncanonical functions of cell cycle regulators in differentiated neurons. Cereb. Cortex 17, 1821\u20131829 (2007).","journal-title":"Cereb. Cortex"},{"key":"1107_CR50","doi-asserted-by":"crossref","unstructured":"Guiley, K. Z. et al. p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition. Science 366, eaaw2106 (2019).","DOI":"10.1126\/science.aaw2106"},{"key":"1107_CR51","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1016\/j.cellsig.2013.05.027","volume":"25","author":"Z Ding","year":"2013","unstructured":"Ding, Z. et al. Transforming growth factor \u03b2 induces expression of connective tissue growth factor in hepatic progenitor cells through Smad independent signaling. Cell. Signal. 25, 1981\u20131992 (2013).","journal-title":"Cell. Signal."},{"key":"1107_CR52","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3390\/ijms17030408","volume":"17","author":"Z-Y Ding","year":"2016","unstructured":"Ding, Z.-Y. et al. Activin A-Smad signaling mediates connective tissue growth factor synthesis in liver progenitor cells. Int. J. Mol. Sci. 17, 408 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"1107_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1478-811X-12-18","volume":"12","author":"L Chen","year":"2014","unstructured":"Chen, L. et al. Activin A induces growth arrest through a SMAD-dependent pathway in hepatic progenitor cells. Cell Commun. Signal. 12, 1\u201314 (2014).","journal-title":"Cell Commun. Signal."},{"key":"1107_CR54","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/978-1-59745-060-7_24","volume":"482","author":"TD Shupe","year":"2009","unstructured":"Shupe, T. D., Piscaglia, A. C., Oh, S., Gasbarrini, A. & Petersen, B. E. Isolation and characterization of hepatic stem cells, or \u2018oval cells,\u2019 from rat livers. Methods Mol. Biol. 482, 387\u2013405 (2009).","journal-title":"Methods Mol. Biol."},{"key":"1107_CR55","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/hep.22079","volume":"47","author":"L Pi","year":"2008","unstructured":"Pi, L. et al. Connective tissue growth factor with a novel fibronectin binding site promotes cell adhesion and migration during rat oval cell activation. Hepatology 47, 996\u20131004 (2008).","journal-title":"Hepatology"},{"key":"1107_CR56","doi-asserted-by":"publisher","first-page":"8078","DOI":"10.1073\/pnas.122210699","volume":"99","author":"L Yang","year":"2002","unstructured":"Yang, L. et al. In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc. Natl Acad. Sci. USA 99, 8078\u20138083 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1107_CR57","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/j.1478-3231.2006.01377.x","volume":"26","author":"A Katoonizadeh","year":"2006","unstructured":"Katoonizadeh, A., Nevens, F., Verslype, C., Pirenne, J. & Roskams, T. Liver regeneration in acute severe liver impairment: a clinicopathological correlation study. Liver Int. 26, 1225\u20131233 (2006).","journal-title":"Liver Int."},{"key":"1107_CR58","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/labinvest.2011.136","volume":"92","author":"AC Dusabineza","year":"2012","unstructured":"Dusabineza, A. C. et al. Participation of liver progenitor cells in liver regeneration: lack of evidence in the AAF\/PH rat model. Lab. Investig. 92, 72\u201381 (2012).","journal-title":"Lab. Investig."},{"key":"1107_CR59","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jss.2014.03.064","volume":"191","author":"S Zhao","year":"2014","unstructured":"Zhao, S. et al. Superparamagnetic iron oxide magnetic nanomaterial-labeled bone marrow mesenchymal stem cells for rat liver repair after hepatectomy. J. Surg. Res. 191, 290\u2013301 (2014).","journal-title":"J. Surg. Res."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01107-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01107-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01107-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T20:04:57Z","timestamp":1661889897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01107-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,31]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1107"],"URL":"https:\/\/doi.org\/10.1038\/s41392-022-01107-7","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,31]]},"assertion":[{"value":"8 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"290"}}